Pfizer recalls all batches of anti-smoking drug Chantix due to the risk of cancer
Pfizer has announced it has recalled all batches of its popular anti-smoking drug Chantix because of the increased risk of cancer due to high nitrosamine levels, according to a Reuters report. When Pfizer halted distribution of the drug in June, a spokesman said the company believed the drug's benefits outweigh the very low ...
Pfizer recalls anti-smoking drug Chantix for potential risk of cancer
Pfizer, the influential pharmaceutical corporation, is recalling 12 batches of Chantix, a popular anti-smoking medication, after detecting excessive levels of a chemical linked to cancer. The Food and Drug Administration (FDA) on July 19 released a statement to inform that Pfizer has widened the voluntary recall of Chantix, or varenicline, to ...
End of content
No more pages to load